Your Directors have pleasure in presenting the 53rd Annual Report and Audited Senior Joint Commissioner,. Kolkata. Delhi Value Added Tax. Ranbaxy Laboratories Limited Annual Report CHAIRMAN’S MESSAGE Down Inc. Germany (upto 16 December ) 11 Ranbaxy Unichem Co. Get Ranbaxy Laboratories latest Balance Sheet, Financial Statements and Ranbaxy Laboratories detailed profit and loss accounts.
In calculating these provisions, the management has used the best information and estimates, presently available. Nifty pares losses; Ranbaxy,Cipla lead 25 Sep 09 Ranbaxy gets approval from Japan for Dewas unit; stk up 24 Jul 09 The amount is excluding interest and penalty, if any.
It also includes a demand of Rs. Nifty bounces over ; Bharti languishes 17 Feb 10 This scheme limits the maximum grant of options to an employee or a director at 30, in any given year. The Company expects to resume API bulk shipments to EU countries from Toansa manufacturing facility upon receipt of clearances from relevant regulatory authorities.
The Company has challenged the order before the Hon”ble Income Tax Appellate Tribunal ITAT and pending disposal of the matter, the management considers the amount of tax liability as unascertainable.
Segment information In accordance with AS 17, Segment Reporting, segment information has been given in the consolidated fnancial statements of the Company, and therefore, no separate disclosure on segment information is given in these fnancial statements. Since the matter involves signifcant judgement and in view of the inherent uncertainty of the present situation, the actual amounts may differ eventually.
The same is expected to be resumed shortly. Daiichi Sankyo Propharma Co. As at 31 Marchthere are no such derivative contracts which are classifed as cash fow hedges. The options vests evenly over a period of three years from the date of grant. Contingent liabilities and commitments to the extent not provided for As at As at 31 March 31 December Contingent liabilities i Guarantees a Letter of comfort on behalf of subsidiaries, to the extent of limits 6, The effective portion of such cash fow hedges was recorded as part of reserves and surplus within hedging reserve and re-classifed in the Statement of Proft and Loss in the period corresponding to the occurrence of the highly probable forecasted transactions.
However, considering the above matters relating to the Toansa manufacturing facility, provisions primarily relating to inventories, trade commitments, sales return etc.
The Company has also issued redeemable non-convertible debentures which are listed for trading on the NSE in India.
Options lapse, if they are not exercised prior to the expiry date, which is ten years from the date of grant. It is the largest exporter of bulk drugs and pharmaceutical dosag. Quick Links for ranbaxylaboratories. These derivatives are anmual used for trading or speculation purposes.
Annual Reports & Presentations
Consequently, stock write off and other costs of Rs. The Company is fully cooperating with this information request and is in dialogue with the US DOJ for submission of the requisite information. Due to the nature of these disputes and also in view of signifcant uncertainty of outcome, the Company believes that the amount of exposure cannot be currently determinable. Hence, the Company has become a potentially sick company in terms of the provisions of Sick Industrial Companies Special Provisions Act, and requisite compliances under this Act would be made by the Company.
Further, the Company has deposited Rs. Dion Global Solutions Limited. The Company received the fnal assessment order from the AO in November whereby demand of Rs The following are the outstanding derivative contracts entered into by the Annjal The ineffectiveness arising from cash fow hedges which was recognised in Statement of Proft and Loss was not material.
Hedging and derivatives a The Company uses various forms of derivative instruments such as foreign exchange forward contracts including instruments which are in substance forward contractsoptions, currency swaps, 20100-11 cum interest rate swaps and interest rate swaps to hedge its exposure to movements in foreign exchange and interest rates. Click here to change registered Email ID.
Thank you for your kind understanding. Foreign funds hint at hiking India allocation 25 Mar 10 A, Italy Ranbaxy Malaysia Sdn. Consequent to the fndings of the above exercise, the carrying amount of inventory has been written down by Rs.
If the shares are listed on more than one stock exchange, then the stock exchange where there is highest trading volume on the said date shall be considered.
Annual Reports | Sun Pharmaceutical Industries Ltd.
Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol. The Company has not accepted the same and ranbaxxy fled its objections before the DRP.
Key markets of US, Europe not so promising 27 Oct 09
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.